Search Results - "Goll, L. G"

Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study by Syversen, S W, Goll, G L, van der Heijde, D, Landewé, R, Lie, B A, Odegård, S, Uhlig, T, Gaarder, P I, Kvien, T K

“…Anti-citrullinated peptide antibodies (ACPAs) are established as useful predictors of radiographic progression in rheumatoid arthritis (RA). The main objective…”
Get more information

High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study by Syversen, S W, Gaarder, P I, Goll, G L, Ødegård, S, Haavardsholm, E A, Mowinckel, P, van der Heijde, D, Landewé, R, Kvien, T K

“…New effective therapies with particularly good effect on joint destruction have highlighted the need for reliable predictors of radiographic progression in…”
Get more information

Serum golimumab concentration and anti-drug antibodies are associated with treatment response and drug survival in patients with inflammatory joint diseases: data from the NOR-DMARD study by Gehin, JE, Warren, DJ, Syversen, SW, Lie, E, Sexton, J, Loli, L, Wierød, A, Bjøro, T, Kvien, TK, Bolstad, N, Goll, GL

“…Objectives: This study aimed to identify the therapeutic target concentration and frequency of anti-drug antibodies (ADAbs) in golimumab-treated patients with…”
Get full text

Metabolic profiling of synovial tissue shows altered glucose and choline metabolism in rheumatoid arthritis samples by Volchenkov, R, Dung Cao, M, Elgstøen, KB, Goll, GL, Eikvar, K, Bjørneboe, O, Bathen, TF, Holen, HL, Kvien, TK, Skålhegg, BS

Get full text

Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care by Glintborg, B, Kringelbach, T, Bolstad, N, Warren, DJ, Eng, G, Sørensen, IJ, Loft, AG, Hendricks, O, Hansen, IMJ, Linauskas, A, Nordin, H, Kristensen, S, Lindegaard, H, Jensen, DV, Goll, GL, Høgdall, E, Gehin, J, Enevold, C, Nielsen, CH, Krogh, NS, Johansen, JS, Hetland, ML

Get full text

Physical map of repetitive DNA and karyotype evolution in three species of the genus Omophoita (Coleoptera: Alticinae) by Mello, L. R. A, Tasior, D, Goll, L. G, Artoni, R. F, Vicari, M. R, Nogaroto, V, Almeida, M. C

“…The order Coleoptera comprises species that are used as models in evolutionary studies, such as Alticinae, which features giant sex chromosomes. Thus, the aim…”
Get full text

Longitudinal changes of serum cytokines in patients with chronic low back pain and Modic changes by Gjefsen, E., Gervin, K., Bråten, L.C.H., Goll, G.L., Aass, H.C.D., Schistad, E.I., Wigemyr, M., Pedersen, L.M., Skouen, J.S., Vigeland, M.D., Selmer, K.K., Storheim, K., Zwart, J.A.

“…To explore serum cytokine levels over time in patients with chronic low back pain (cLBP) and Modic changes (MCs), difference in change between treatment groups…”
Get full text

Interleukin‐15 Induces Interleukin‐17 Production by Synovial T Cell Lines from Patients with Rheumatoid Arthritis by Halvorsen, E. H., Strønen, E., Hammer, H. B., Goll, G. L., Sollid, L. M., Molberg, Ø.

“…IL‐17‐producing T cells (Th17 cells) are believed to contribute to local inflammation and joint damage in rheumatoid arthritis (RA). Limited data exist on Th17…”
Get full text

Cytogenetic analysis of Lagria villosa (Coleoptera, Tenebrionidae): emphasis on the mechanism of association of the Xy(p) sex chromosomes by Goll, L G, Artoni, R F, Vicari, M R, Nogaroto, V, Petitpierre, E, Almeida, M C

“…The Xy(p) sex determination mechanism is the system most frequent and ancestral to Coleoptera. Moreover, the presence of argyrophilous material associated with…”
Get more information

P1056 T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients with inflammatory bowel disease on TNF inhibitor treatment, a prospective cohort study by Bjørlykke, K H, Wolf, A S, Ørbo, H S, Bhandari, S, Solum, G, Kjønstad, I F, Lund, K P, Tveter, A T, Sexton, J, Jyssum, I, Kro, G B, Jahnsen, J, Haavardsholm, E A, Grødeland, G, Provan, S A, Kared, H, Lund-Johansen, F, Munthe, L A, Syversen, S W, Goll, G L, Mjaaland, S, Jørgensen, K K

“…Abstract Background Understanding T cell responses to SARS-CoV-2 immunisation in patients on immunosuppressive treatment is important for future vaccine…”
Get full text

P696 Genetic predisposition to infliximab immunogenicity in patients with immune-mediated inflammatory diseases – secondary analyses from a randomised clinical trial by Bjørlykke, K, Brun, M K, Viken, M K, Stenvik, G E, Klaasen, R A, Gehin, J E, Warren, D J, Sexton, J, Haavardsholm, E A, Jahnsen, J, Lie, B A, Goll, G L, Bolstad, N, Syversen, S W, Jørgensen, K K

“…Abstract Background Immunogenicity is a leading cause of treatment failure to TNF inhibitors. Genetic variations in HLA class II genes have been suggested to…”
Get full text

OP09 Proactive Therapeutic Drug Monitoring is superior to standard treatment during maintenance therapy with infliximab; results from a 52-week multicentre randomised trial of 450 patients; the NOR-DRUM B study by Jørgensen, K K, Syversen, S W, Goll, G L, Bjørlykke, K H, Sandanger, Ø, Sexton, J, Brun, M K, Noraberg, G, Ystrøm, C M, Seeberg, K A, Blomgren, I M, Torp, R, Mørk, C, Kvien, T K, Bolstad, N, Haavardsholm, E A, Jahnsen, J

“…Abstract Background Proactive therapeutic drug monitoring (TDM), individualized treatment based on scheduled assessments of serum drug levels, has been…”
Get full text

P605 Immunogenicity and safety of standard and third dose SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases; a prospective cohort study by Jørgensen, K K, Syversen, S W, Jyssum, I, Tveter, A T, Tran, T T, Sexton, J, Provan, S A, Mjaaland, S, Warren, D J, Kvien, T K, Grødeland, G, Nissen-Meyer, L S, Ricanek, P, Chopra, A, Andersson, A M, Kro, G B, Jahnsen, J, Munthe, L A, Haavardsholm, E A, Vaage, J T, Lund-Johansen, F, Goll, G L

“…Abstract Background The immunogenicity and safety following standard two-dose SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases…”
Get full text

P483 Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: Explorative subgroup analyses in IBD from the NOR-SWITCH EXTENSION trial by Jørgensen, K K, Goll, G L, Sexton, J, Olsen, I C, Bolstad, N, Lundin, K E, Berset, I P, Haavardsholm, E A, Mørk, C, Kvien, T K, Jahnsen, J

“…Abstract Background TNF-inhibitors have improved treatment of Crohn’s disease (CD), ulcerative colitis (UC), rheumatoid arthritis, spondyloarthritis, psoriatic…”
Get full text

Biomarkers in early rheumatoid arthritis: longitudinal associations with inflammation and joint destruction measured by magnetic resonance imaging and conventional radiographs by Syversen, Silje W, Haavardsholm, Espen A, Bøyesen, Pernille, Goll, Guro L, Okkenhaug, Cecilie, Gaarder, Per Ivar, van der Heijde, Désirée, Kvien, Tore K

“…To examine associations between a panel of soluble biomarkers and progressive joint destruction assessed by magnetic resonance imaging (MRI) and conventional…”
Get more information

Therapeutic drug monitoring in inflammatory bowel disease: implementation, utilization, and barriers in clinical practice in Scandinavia by Bjørlykke, Kristin H., Jahnsen, Jørgen, Brynskov, Jørn, Molander, Pauliina, Eberhardson, Michael, Davidsdottir, Loà G., Sipponen, Taina, Hjortswang, Henrik, Goll, Guro Løvik, Syversen, Silje Watterdal, Langholz, Ebbe, Jørgensen, Kristin K., Steenholdt, Casper

“…Therapeutic drug monitoring (TDM) may optimize biologic and thiopurine therapies in inflammatory bowel disease (IBD). The study aimed to investigate…”
Get full text